Cannabidiols In Supplements Unlike CBD Isolate Approved As Drug, Attorneys Say
Executive Summary
As many as 100 ingredients are identified in hemp and cannabis plants, and FDA could be impeding even faster growth of CBD-containing supplement and food market by insisting that all those substances are the same as the CBD isolate active ingredient in Epidiloex, say FDLI's first conference entirely on regulation of cannabis and hemp products market.
You may also be interested in...
FDA ISO Data On CBD Safety In Supplements, Sees Potential As Well As Risks
There's a reason the FDA continues accepting comments on questions about using hemp- and cannabis-derived ingredients in products other than drugs months after the comment period closed. "It's safe to say say that in 4,500 comments, we did not receive a lot of hard data around the issues that we specifically requested comments on," says Sharon Mayl, senior advisor for policy in the commissioner's office.
CBD Products For Children Could Connect The Dots To FDA's Problem For Congress
In addition to FDA and FTC attention, pediatric claims by Rooted Apothecary could get attention of US lawmakers, who FDA is asking to authorize it to more directly enforce against adulterated supplements. Violative claims include “Increasing evidence suggests that CBD oil is a powerful option for pain and autism. It seems like an attractive and safe option for children.”
FDA Clearing CBD As Dietary Ingredient? Legislation More Likely Than Rulemaking
Senate Appropriations subcommittee members add to Capitol Hill's push for FDA to change its current regulatory stance that CBD is deemed noncompliant for use in supplements and food. Commissioner Gottlieb suggests legislation authorizing FDA to allow use of CBD up to certain concentrations in supplements and food products. FDA currently allows sales of food and supplements containing CBD under enforcement discretion.